Christopher A Eide Selected Research

Cyclin-Dependent Kinases (cdk Proteins)

11/2014

BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher A Eide Research Topics

Disease

28	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2022 - 03/2007
24	Neoplasms (Cancer) 11/2023 - 07/2006
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 07/2006
12	Leukemia 01/2022 - 04/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 07/2010
6	Philadelphia Chromosome 10/2022 - 01/2008
4	Hematologic Neoplasms (Hematological Malignancy) 12/2019 - 01/2016
3	Disease Progression 12/2022 - 01/2011
3	Blast Crisis (Blast Phase) 12/2022 - 04/2017
2	Polycythemia Vera 01/2020 - 01/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2008
2	Lung Neoplasms (Lung Cancer) 01/2016 - 11/2013
2	Adenocarcinoma of Lung 01/2016 - 11/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015 - 11/2013
1	T-Cell Leukemia (Leukemia, T Cell) 10/2023
1	Splenomegaly 01/2018
1	Juvenile Myelomonocytic Leukemia 01/2018
1	Medulloblastoma 10/2017
1	Chronic Neutrophilic Leukemia 02/2016
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 02/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2015
1	Carcinogenesis 11/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2014
1	Cholangiocarcinoma 11/2013
1	Glioblastoma (Glioblastoma Multiforme) 11/2013
1	Genetic Translocation (Chromosomal Translocation) 01/2008
1	Hodgkin Disease (Hodgkin's Disease) 01/2008

Drug/Important Bio-Agent (IBA)

26	Phosphotransferases (Kinase)IBA 12/2022 - 07/2006
14	Imatinib Mesylate (Gleevec)FDA Link 09/2014 - 03/2007
11	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2011
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 04/2008
6	ponatinibIBA 10/2019 - 11/2009
6	Dasatinib (BMS 354825)FDA Link 01/2016 - 11/2009
4	venetoclaxIBA 11/2023 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2013
4	nilotinib FDA Link 12/2011 - 11/2009
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
3	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 04/2014
3	DCC-2036IBA 11/2011 - 01/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 12/2011
2	ibrutinibIBA 01/2020 - 05/2018
2	CrizotinibIBA 01/2016 - 11/2013
2	Anaplastic Lymphoma KinaseIBA 09/2015 - 06/2015
2	Tyrosine (L-Tyrosine)FDA Link 05/2008 - 07/2006
1	Azacitidine (5 Azacytidine)FDA Link 11/2023
1	AntibodiesIBA 10/2023
1	Glycerophospholipids (Phosphoglycerides)IBA 12/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	doramapimodIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase 14IBA 01/2022
1	Aurora Kinase AIBA 11/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Erythropoietin FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	crenolanibIBA 01/2019
1	snake venom protein C activatorIBA 01/2019
1	idelalisibIBA 05/2018
1	BiguanidesIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Protein Tyrosine PhosphatasesIBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Drug CombinationsIBA 01/2017
1	ruxolitinibIBA 02/2016
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2016
1	Bcl-2-Like Protein 11IBA 01/2016
1	SolventsIBA 01/2016
1	cabozantinibIBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 12/2015
1	src-Family KinasesIBA 12/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2014
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2014
1	Cell-Penetrating PeptidesIBA 04/2014
1	GSK 1363089IBA 11/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2010
1	Amino Acids FDA Link 02/2009
1	Chlorambucil (Leukeran)FDA Link 01/2008
1	bcr-abl Fusion ProteinsIBA 03/2007

Therapy/Procedure

23	Therapeutics 11/2023 - 03/2008
1	Molecular Targeted Therapy 03/2007